Dietary impact on blood-brain barrier tight junctions
Dietary impact on blood-brain barrier tight junctions
批准号:
9113099
负责人:
KEN A WITT
金额:
$18.06万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2018-07-31
关键词:
AcuteAddressAge-MonthsAlzheimer&aposs DiseaseBacterial ProteinsBloodBlood - brain barrier anatomyBrainC57BL/6 MouseCentral Nervous System DiseasesCerebrovascular DisordersChronicComplexDataDietDietary FatsDiffusionDiseaseDisease OutcomeDocosahexaenoic AcidsEicosapentaenoic AcidEndothelial CellsEpidemicEvaluationFat-Restricted DietFatty acid glycerol estersFoundationsFunctional disorderFutureGoalsHealthHomeostasisImmuneInflammationInflammatoryInjection of therapeutic agentLigandsLipopolysaccharidesMetabolic syndromeMultiple SclerosisNational Center for Complementary and Alternative MedicineNational Institute of Neurological Disorders and StrokeNational Institute on AgingNeurodegenerative DisordersObesityOmega-3 Fatty AcidsPPAR gammaPermeabilityPhenotypePolyunsaturated Fatty AcidsPredispositionProcessPropertyProteinsRegulationRunningSiteSocietiesStrokeTight JunctionsTimeUnited States National Institutes of Healthbasebrain healthdietary supplementsinsightnovelpublic health relevanceresiliencesaturated fatwestern diet
中文摘要
英文摘要
DESCRIPTION (provided by applicant): A critical property of the blood-brain barrier (BBB) is the unique complex of tight junctions (TJs) that exist between adjacent endothelial cells, which impede paracellular diffusion and help maintain brain homeostasis. Numerous lines of evidence implicate BBB TJ dysfunction as a primary contributor to central nervous system (CNS) disease. While it has become increasingly evident that pro-inflammatory high-fat "Western" diets contribute to CNS disease, the impact of such diets on the BBB TJs has not been fully elucidated. Likewise, the potential benefit of omega-3 (ω3) polyunsaturated fatty acids (PUFAs) on BBB TJ regulation also remains unclear. The goal of this examination is to elucidate the effects of dietary fats on BBB TJ integrity and protein regulation, respective to inflammatory contributions. This study is divided into two aims: 1) Determine the effect of Western vs. omega-3 based diets on BBB TJ integrity and protein regulation over time. Evaluations of BBB TJ protein regulation (microvascular isolate) and paracellular integrity (permeability marker) corresponding with high and low fat diets, both with and without primary ω-3 PUFAs (EPA and DHA), will be assessed over 14- and 28-weeks of dietary treatment (C57BL/6 mice). Supportive evaluations will assess primary dietary variables, inflammatory components, and PPARγ alterations. 2) Determine the effect of Western vs. omega-3 based diets on BBB TJ integrity and protein regulation against an acute inflammatory challenge. Herein, 14-week dietary treatments will be run against an acute inflammatory challenge via lipopolysaccharide (LPS), followed by evaluation sets identified in aim-1. Assessing BBB TJs at key inflammatory time-points, post-LPS injection, will allow for the delineation of BBB TJ susceptibility and resilience respective to
dietary treatments. This exploratory study will provide novel insight into the impact of dietary fas on the health and resilience of the BBB TJs, as well as a greater understanding of inflammatory influences. Additionally, it will serve as the foundation for future examinations respective to BBB
regulation and disease outcomes. The aims of this study address priorities of National Institutes of Health, respective to the National Institute of Neurological Disorders and Stroke (NINDS), National Institute on Aging (NIA), National Center for Complementary and Alternative Medicine (NCCAM), and the Office of Dietary Supplements (ODS).
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1093/cdn/nzy065
发表时间:
2018-10
期刊:
Current developments in nutrition
影响因子:
4.8
作者:
[Sandoval KE, Wooten JS, Harris MP, Schaller ML, Umbaugh DS, Witt KA]
通讯作者:
Witt KA
Lead optimization of somatostatin-based therapeutic for Alzheimer's Disease
-
批准号:9523400
-
项目类别:
-
资助金额:$18.12万
-
财政年份:2015
-
负责人:KEN A WITT
-
依托单位:
Lead optimization of somatostatin-based therapeutic for Alzheimer's Disease
-
批准号:8884365
-
项目类别:
-
资助金额:$55.36万
-
财政年份:2015
-
负责人:KEN A WITT
-
依托单位:
Lead optimization of somatostatin-based therapeutic for Alzheimer's Disease
-
批准号:9086193
-
项目类别:
-
资助金额:$50.61万
-
财政年份:2015
-
负责人:KEN A WITT
-
依托单位:
Somatostatin Agonist Treatment for Cognitive Aging and Dementia
-
批准号:7930663
-
项目类别:
-
资助金额:$14.64万
-
财政年份:2009
-
负责人:KEN A WITT
-
依托单位:
Blood-brain barrier changes via hypoxia/re-oxygenation
-
批准号:6640460
-
项目类别:
-
资助金额:$4.64万
-
财政年份:2002
-
负责人:KEN A WITT
-
依托单位:
Blood-brain barrier changes via hypoxia/re-oxygenation
-
批准号:6549898
-
项目类别:
-
资助金额:$3.83万
-
财政年份:2002
-
负责人:KEN A WITT
-
依托单位:
Blood-brain barrier changes via hypoxia/re-oxygenation
-
批准号:6801831
-
项目类别:
-
资助金额:$4.89万
-
财政年份:2002
-
负责人:KEN A WITT
-
依托单位:
海外基金